Financials aap Implantate AG Xetra

Equities

AAQ

DE0005066609

Medical Equipment, Supplies & Distribution

End-of-day quote Xetra 04:30:00 05/02/2024 am IST 5-day change 1st Jan Change
0.73 EUR -2.67% Intraday chart for aap Implantate AG -9.32% -12.05%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 51.52 32.4 11.93 10.1 14.93 8.047
Enterprise Value (EV) 1 36.68 25.93 10.27 13.07 17.91 10.98
P/E ratio -5.56 x -4.19 x -0.61 x -1.13 x -5.85 x -3.14 x
Yield - - - - - -
Capitalization / Revenue 4.15 x 2.56 x 0.92 x 1.07 x 1.21 x 0.69 x
EV / Revenue 2.95 x 2.05 x 0.79 x 1.39 x 1.46 x 0.94 x
EV / EBITDA -6.37 x -4.57 x -0.57 x -2.22 x -7.3 x -3.43 x
EV / FCF -20.3 x -5.51 x -1.1 x -8.07 x -7.2 x -5.8 x
FCF Yield -4.92% -18.2% -90.5% -12.4% -13.9% -17.2%
Price to Book 1.21 x 0.93 x 0.63 x 0.98 x 1.17 x 0.69 x
Nbr of stocks (in thousands) 2,864 2,867 3,207 3,207 4,978 5,961
Reference price 2 17.99 11.30 3.720 3.150 3.000 1.350
Announcement Date 30/03/18 30/04/19 30/06/20 30/04/21 31/03/22 29/04/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 12.42 12.68 12.98 9.405 12.3 11.66
EBITDA 1 -5.757 -5.669 -18.01 -5.887 -2.453 -3.201
EBIT 1 -6.96 -6.832 -19.28 -7.441 -3.353 -4.042
Operating Margin -56.04% -53.89% -148.49% -79.12% -27.26% -34.67%
Earnings before Tax (EBT) 1 -9.3 -7.648 -20.04 -8.816 -2.864 -3.613
Net income 1 -9.271 -7.666 -19.44 -8.937 -2.522 -2.564
Net margin -74.65% -60.47% -149.73% -95.02% -20.5% -22%
EPS 2 -3.237 -2.700 -6.100 -2.787 -0.5131 -0.4305
Free Cash Flow 1 -1.803 -4.706 -9.3 -1.62 -2.487 -1.894
FCF margin -14.52% -37.12% -71.63% -17.23% -20.22% -16.25%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/03/18 30/04/19 30/06/20 30/04/21 31/03/22 29/04/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 2.97 2.97 2.94
Net Cash position 1 14.8 6.48 1.66 - - -
Leverage (Debt/EBITDA) - - - -0.5045 x -1.212 x -0.9172 x
Free Cash Flow 1 -1.8 -4.71 -9.3 -1.62 -2.49 -1.89
ROE (net income / shareholders' equity) -19% -19.8% -72.3% -61.3% -21.9% -20%
ROA (Net income/ Total Assets) -7.61% -9.21% -35.2% -20.2% -9.82% -11.7%
Assets 1 121.8 83.2 55.26 44.19 25.67 21.91
Book Value Per Share 2 14.90 12.20 5.880 3.210 2.570 1.950
Cash Flow per Share 2 4.640 1.480 0.9100 0.2800 0.4200 0.0400
Capex - - 0.41 0.33 0.33 0.34
Capex / Sales - - 3.13% 3.55% 2.67% 2.95%
Announcement Date 30/03/18 30/04/19 30/06/20 30/04/21 31/03/22 29/04/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
Number of Analysts
0
Last Close Price
1.21
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AAQ1 Stock
  4. AAQ Stock
  5. Financials aap Implantate AG